We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$212M
AUM Growth
+$16.7M
(+8.5%)
Cap. Flow
+$11.9M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
65
New
3
Increased
31
Reduced
4
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LHCG
LHC Group LLC
LHCG
|
+$4.64M |
| 2 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$4.57M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
+$4.24M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.95M |
| 5 |
AtriCure
ATRC
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$3.97M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$3.7M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
+$3.37M |
| 4 |
STAAR Surgical
STAA
|
+$2.53M |
| 5 |
NeoGenomics
NEO
|
+$1.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.38% |
| 2 | Energy | 2.37% |
| 3 | Consumer Staples | 0.82% |
| 4 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
51
DELISTED
St Jude Medical
STJ
| $442K | 0.21% |
6,055
| – | – |
|
52
Steris
STE
$22.3B
| $408K | 0.19% |
6,330
| – | – |
|
53
Community Health Systems
CYH
$393M
| $387K | 0.18% |
7,435
| – | – |
|
54
Merck
MRK
$322B
| $376K | 0.18% |
6,927
| – | – |
|
55
Johnson & Johnson
JNJ
$618B
| $372K | 0.18% |
3,820
| – | – |
|
56
AstraZeneca
AZN
$263B
| $362K | 0.17% |
5,680
| – | – |
|
57
Amgen
AMGN
$208B
| $358K | 0.17% |
2,330
| – | – |
|
58
Pfizer
PFE
$143B
| $353K | 0.17% |
11,088
| – | – |
|
59
Sanofi
SNY
$103B
| $281K | 0.13% |
5,680
| – | – |
|
60
Myriad Genetics
MYGN
$270M
| $266K | 0.13% |
7,820
| – | – |
|
61
Bio-Rad Laboratories Class A
BIO
$8.71B
| $252K | 0.12% |
1,675
| – | – |
|
62
Agilent Technologies
A
$39.1B
| – | – |
-5,120
| Closed | -$213K |
|
|
63
STAAR Surgical
STAA
$1.21B
| – | – |
-340,662
| Closed | -$2.53M |
|
|
LCI
64
DELISTED
Lannett Company, Inc.
LCI
| – | – |
-12,442
| Closed | -$3.37M |
|
|
NVDQ
65
DELISTED
Novadaq Technologies Inc.
NVDQ
| – | – |
-244,238
| Closed | -$3.97M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, First Light Asset Management held 65 positions worth $212M, up 8.5% from $196M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Light Asset Management deployed $11.9M of net new capital in Q2 2015, opening 3 new positions and adding to 31 existing holdings. Its largest new stake was LHC Group LLC: 131,467 shares worth $5.03M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 89% a quarter earlier, followed by Energy and Consumer Staples.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $3.7M trimmed.
- First Light Asset Management's largest Q2 2015 buy was LHC Group LLC: 131,467 shares worth $5.03M.
- First Light Asset Management added most to AMAG Pharmaceuticals in Q2 2015, an estimated $4.57M increase.
- First Light Asset Management's biggest Q2 2015 reduction was Ligand Pharmaceuticals, cutting an estimated $3.7M.
- First Light Asset Management fully exited Novadaq Technologies Inc. in Q2 2015, selling an estimated $3.97M.
- First Light Asset Management's ten largest holdings make up 47% of its $212M portfolio in Q2 2015.
- First Light Asset Management opened 3 new positions and closed 4 in Q2 2015.
- First Light Asset Management's portfolio value rose 8.5% quarter-over-quarter to $212M.
Based on First Light Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.